Comparison of the prevention of aflatoxin B1-induced genotoxicity by quercetin and quercetin pentaacetate

Bioorganic and Medicinal Chemistry Letters

Volumn 12, Issue 18, 2002, Pages 2579-2582

  Kohli, Ekta ^a   Raj, Hanumantharao G ^a   Kumari, Ranju ^a   Rohil, Vishwajit ^a   Kaushik, Narendra K ^b   Prasad, Ashok K ^b   Parmar, Virinder S ^b  

^a UNIVERSITY OF DELHI   (India)

^b UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID DERIVATIVE; ACETOXY 4 METHYLCOUMARIN; ACYLTRANSFERASE; AFLATOXIN B1; COUMARIN DERIVATIVE; CYTOCHROME P450; DNA; ENZYME; GLUTATHIONE TRANSFERASE; QUERCETIN; QUERCETIN PENTAACETATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CATALYSIS; CONTROLLED STUDY; DNA BINDING; DRUG MECHANISM; EPOXIDATION; GENOTOXICITY; LIVER MICROSOME; MALE; NONHUMAN; RAT; TIME;

AFLATOXIN B1; ANIMALS; ANTIMUTAGENIC AGENTS; BONE MARROW CELLS; CATALYSIS; CYTOCHROME P-450 ENZYME SYSTEM; MALE; MICRONUCLEUS TESTS; MICROSOMES, LIVER; NADPH-FERRIHEMOPROTEIN REDUCTASE; QUERCETIN; RATS; RATS, WISTAR;

EID: 0037119828     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(02)00478-X     Document Type: Article

References (21)

1. Guengerich F.P., Kim D.H. Carcinogenesis. 11:1990;2275.
2. Newmark H.C. Dietary Phytochemicals in Cancer Prevention and Treatment: Advances in Experimental Medicine and Biology. 1996;American Institute for Cancer Research; Plenum, New York. Vol. 401.
3. Wang Z.Y., Huang M.T., Ferraro T., Wong C.Q., Lou Y.R., Reuhl K., Iatropoulos M.C., Yang S., Conney A.H. Cancer Res. 52:1970;1162.
4. Wang Z.Y., Wang L.D., Lee M.J., Ho C.T., Huang M.T., Canney A.H., Yang C.S. Carcinogenesis. 16:1995;2143.
5. Anderson D., Dobzynska M.M., Basavan N., Basavan A., Yu T.W. Mutat. Res. 402:1998;269.
6. Smith, T. J.; Yang, C. S. In Food Phytochemicals for Cancer Prevention; Huang, M. T.; Osawa, T.; Ho, C. T.; Rosen, R. T. Eds.; American Chemical Society Symposium Series; Washington, DC, 1994; Vol. 546.
7. Raj H.G., Parmar V.S., Jain S.C., Goel S., Singh A., Gupta K., Rohil V., Tyagi Y.K., Jha H.N., Olsen C.E., Wengel J. Bioorg. Med. Chem. 6:1998;1895.
8. Raj H.G., Parmar V.S., Jain S.C., Goel S., Singh A., Tyagi Y.K., Jha H.N., Olsen C.E., Wengel J. Bioorg. Med. Chem. 7:1999;369.
9. Raj H.G., Malik S., Parmar V.S., Kohli E., Tyagi Y.K., Rohil V., Dwarakanath B.S., Adhikari J.S., Bose M., Jain S.C., Olsen C.E. Teratogen. Carcinogen. Mutagen. 21:2001;181.
10. Raj H.G., Kohli E., Rohil V., Dwarakanath B.S., Parmar V.S., Malik S., Adhikari J.S., Tyagi Y.K., Goel S., Gupta K., Bose M., Olsen C.E. Mutat. Res. 494:2001;31.
11. Raj H.G., Parmar V.S., Jain S.C., Kohli E., Ahmed N., Goel S., Tyagi Y.K., Sharma S.K., Wengel J., Olsen C.E. Bioorg. Med. Chem. 8:2000;1707.
12. Raj H.G., Parmar V.S., Kohli E., Tyagi Y.K., Jain S.C., Olsen C.E. FASEB J. 14:2000;1445.
13. Allameh A., Saxena M., Raj H.G. Cancer Lett. 40:1988;49.
14. Wang T.V., Cerutti P. A. Cancer Res. 39:1979;5165.
15. Burton K. Biochem. J. 62:1956;315.
16. Schmid W.T. Mutat. Res. 31:1975;9.
17. Raj H.G., Gupta K., Rohil V., Bose M., Biswas G., Singh S.K., Jain S.C, Parmar V.S., Olsen C.E., Wengel J. Teratogen. Carcinogen. Mutagen. 18:1998;249.
18. Kohli E., Kumari R., Gupta G., Raj H.G., Parmar V.S., Ahmad N., Jain S.C., Olsen C.E. Drug Metab. Rev. 33(Suppl. 1):2001;39.
19. Singh. I.; Kohli E.; Raj, H. G.; Gyanda, K. K.; Jain, S. K.; Tyagi, Y. K.; Gupta, G.; Kumari, R.; Kumar, A.; Pal, G.; Prasad, A. K.; Rastogi, R. C.; Olsen, C. E.; Jain, S. C.; Parmar, V. S. Bioorg. Med. Chem. In press.
20. Alliangana D.M. East. Afr. Med. J. 73:1996;752.
21. Stefansen M., Mattache C., Oma A., Szegli G. Roum. Arch. Microbiol. Immunol. 56:1997;3.